Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Ublituximab, a Novel, Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), Demonstrates Enhanced Antibody-Dependent Cellular Cytotoxicity (ADCC) Relative to Other Anti-CD20 mAbs

Author:Huang, Deren   Alvarez, Enrique   Miskin, Hari   Lee, Lily   Foley, John   

Session Name:P7: MS Therapeutics 1  

Topic:MS and Inflammatory Disease  

Program Number:P7.011  

Author Institution:Mount Carmel Neurology, Powell, OH  University of Colorado, Aurora, CO  TG Therapeutics, New York, NY  Rocky Mountain MS Clinic, Salt Lake City, UT  

A Quantitative Approach to Telemedicine Assessment of Ptosis and Ocular Motility for Patients with Myasthenia Gravis

Author:Lesport, Quentin   Joerger, Guillaume   Kaminski, Henry   Girma, Helen   McNett, Sienna   Abu-Rub, Mohammad   Garbey, Marc   

Session Name:P7: Neuromuscular Disease: Neuromuscular Junction Disorders 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P7.011  

Author Institution:The George Washington University, Washington, DC  ORintelligence LLC, Houston, TX  The George Washington University, Washington , DC  George Washington University, Washington, DC  ORintelligence LLC, Washington, DC